Detalles de la búsqueda
1.
Pimavanserin for Parkinson's Disease psychosis: Effects stratified by baseline cognition and use of cognitive-enhancing medications.
Mov Disord
; 33(11): 1769-1776, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30387904
2.
Pimavanserin for the treatment of Parkinson's disease psychosis: number needed to treat, number needed to harm, and likelihood to be helped or harmed.
CNS Spectr
; 23(3): 228-238, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29098976
3.
In Vitro Stability and Recovery Studies of Pimavanserin in Water and in Different Vehicles Orally Administered.
Drugs R D
; 22(1): 95-104, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35107816
4.
Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patients.
Parkinsonism Relat Disord
; 87: 25-31, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33933853
5.
An Open-Label, 8-Week Study of Safety and Efficacy of Pimavanserin Treatment in Adults with Parkinson's Disease and Depression.
J Parkinsons Dis
; 10(4): 1751-1761, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32804101
6.
CPR to the Rescue!: An Interprofessional Pilot Program: Cultivating Practices for Resilience (CPR) Camp.
Clin Nurse Spec
; 34(2): 63-69, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32068634
7.
Long-term evaluation of open-label pimavanserin safety and tolerability in Parkinson's disease psychosis.
Parkinsonism Relat Disord
; 77: 100-106, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32712560
8.
Parkinson's disease and Parkinson's disease psychosis: a perspective on the challenges, treatments, and economic burden.
Am J Manag Care
; 23(5 Suppl): S83-S92, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28715903
9.
Dissemination of Evidence From Systematic Reviews Through Academic CME Providers: A Feasibility Study.
J Contin Educ Health Prof
; 36(2): 104-12, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27262153
Resultados
1 -
9
de 9
1
Próxima >
>>